Journal

Hidradenitis suppurativa: Current and emerging treatments

Read time: 1 mins

Published:30th Apr 2020

Author: Goldburg SR, Strober BE, Payette MJ.

Source: Journal of the American Academy of Dermatology

Availability: Pay for access, or by subscription

Ref.:J Am Acad Dermatol. 2020 May;82(5):1061-1082.

DOI:10.1016/j.jaad.2019.08.089

Hidradenitis suppurativa: Current and emerging treatments

The treatment of hidradenitis suppurativa (HS) has remained challenging because of the many knowledge gaps regarding etiology. However, recent studies into the pathogenesis of HS have enabled the investigation of newer therapies. The second article in this continuing medical education series reviews the evidence for established therapies for HS, including anti-inflammatories, antibiotics, and surgery. New and emerging therapies that specifically target cytokines involved in HS pathogenesis will be covered. The potential therapeutic roles of anticytokine therapies, including both the expanded application of existing molecules as well as the specific development of novel therapies for HS are discussed. With increased attention on HS and with numerous clinical trials currently underway, we hope that the variety of treatment options for HS will be expanded.

Read abstract on library site Access full article